Skip to content
LATEST
US Politics

NIH and FDA Nominees Linked to New Academic Journal Launch

NIH and FDA nominees are linked to a new, controversial academic journal, raising questions about potential conflicts of interest and future shifts in…

NIH and FDA Nominees Linked to New Academic Journal Launch

Jay Bhattacharya, the nominee for Director of Institutes of Health (NIH), and Marty Makary, the nominee for Commissioner of the Food and Drug Administration (FDA), have been identified as co-founders or editorial board members of the newly established Journal of the Academy of Public Health. Both nominees are currently listed as being on leave from the publication. The journal, which promotes open-access publishing and public peer review, was established to challenge existing commercial academic publishing models.

The journal’s editorial board includes several researchers who previously advocated for COVID-19 policies that diverged from established public health consensus, including proponents of the Great Barrington Declaration. The publication has already released articles questioning the efficacy of mask mandates in schools and examining potential links between vaccine components and health conditions. The launch was facilitated by the RealClearFoundation, an organization associated with conservative philanthropic backing.

Members of the scientific community have expressed skepticism regarding the journal’s governance structure, noting that publication rights are restricted to members of the affiliated Academy of Public Health, with new membership contingent upon existing member approval. Critics have raised concerns that the journal’s founders may seek to institutionalize their critiques of traditional academic publishing and public health standards once they assume leadership roles at federal health agencies.

Questions remain regarding the operational status of the Academy of Public Health and the potential for conflicts of interest as the nominees transition into federal oversight roles. Observers are monitoring whether the appointees will maintain their affiliation with the journal or if their involvement will influence future federal research funding and regulatory standards. The intersection of these academic initiatives with the incoming administration’s health policy agenda remains a focal point for institutional risk assessment.

More stories

Latest news